Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sterilex is a leading developer of innovative solutions for biofilm control, disinfection, and microbial decontamination. The company's proprietary PerQuat technology is the only chemistry with EPA-registered claims to penetrate and remove biofilms on food contact surfaces and in healthcare settings. Sterilex serves diverse industries, including food and beverage processing, animal health, and clinical healthcare, providing products that enhance safety and operational efficiency. Their portfolio includes EPA-registered disinfectants, sanitizers, and specialized cleaners designed to eliminate resistant pathogens. By focusing on the intersection of chemistry and microbiology, Sterilex helps organizations mitigate the risks associated with microbial contamination and biofilm-related issues.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sterilex.